News

Early work has begun at the AIBN on a synthetic, drug-free solution that helps osteoarthritis patients with problem joints.

When it comes to precision medicine, advanced biomanufacturing and nanoengineered materials, if you dream it, the AIBN can do it.

Professor Kris Thurecht and the AIBN team are working to improve the targeting ability of these molecules to unlock the power of radiopharmaceuticals.

A University of Queensland (UQ) developed antiviral surface coating that protects against COVID-19 and other existing and emerging viral and bacterial transmissions is being tested on the International Space Station.

AIBN researchers want HIV patients to have the option of taking a long-acting antiretroviral dose once a week, instead of having to take a dose every day.

AIBN researchers are exploring potential nanoscale processes that explain how the body's text messages move about.

The gold standard test for oesophageal cancer involves a tube being stuck down your throat. PhD scholar Ramlah Khamis is working on a better method that could, in turn, help lift survival rates.

AIBN researchers are developing new 4D printing technology that produces shape-shifting liquid metals for soft robotics.

From environmental and energy technologies to biofuels, organoids, and new platforms for vaccines and therapeutics, here’s a wrap of the AIBN's biggest moments from the past 12 months – and some exciting developments we’re looking forward to in 2024.

Researcher Jacob Earnshaw has joined the growing list of AIBN PhD scholars to embark on a UQ Startup AdVenture. This is what he picked up during his time in Singapore's busting entrepreneurial scene.

Could specific sensor techniques help us dodge a looming zoonotic COVID-19 threat? AIBN researchers are gathering evidence that suggests so.

AIBN researchers are using synthetic brain organoid models, grown in a laboratory from human stem cells, to find new ways to rejuvenate brains that have been prematurely aged by COVID-19.

Two exciting AIBN projects have scored new funding to help industry collaborators crack the lucrative computer chip industry and capitalise on opportunities in waste-to-catalyst conversion

In 2023, a cure for ALS remains elusive, and there are still no treatments to reverse its effects. But AIBN researchers are piecing together information that could get us there.

Four AIBN-led projects have been recognised in latest round of the $220 million Australian Research Council Discovery scheme, a program that recognises research with economic, commercial, environmental, social and/or cultural benefits.

A new parcel of funding from the Australian Research Council (ARC) will establish a cutting-edge national network for magnetic resonance spectroscopy – and the AIBN’s Centre for Advanced Imaging is set to play a central role.

mRNA vaccines and therapies will be produced for clinical trials in a dedicated laboratory to be built at the Australian Institute for Bioengineering and Nanotechnology.

There has been a huge increase in studies on extracellular vesicles, as these biological ‘text messages’ can be harnessed to develop therapeutic and diagnostic approaches for diseases, such as cancer.

New AIBN battery technology to help meet the global electrification demand has taken another step towards commercialisation.

It is well known that estrogen is a sex hormone – but can it also help to relieve low back pain and osteoarthritis pain?